Publication:
Impact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR.

cris.virtualsource.author-orcid093687ae-09e2-4fb7-9644-881258cb30f4
cris.virtualsource.author-orcidfafbcdd0-8c14-476a-bb7d-cf86fda8e744
cris.virtualsource.author-orcid51373a0c-6282-4884-bb5e-09ddec6eebd6
cris.virtualsource.author-orcide58d604d-1e1c-4387-94ae-cf69dd2a3ea3
cris.virtualsource.author-orcid6065cac3-a8d9-4720-8f5e-90e80751ce15
cris.virtualsource.author-orcid31134751-5aa4-429b-82a9-a4f94bac9190
cris.virtualsource.author-orcidcd371550-d0e7-4ed5-9c7b-6cc359ec33de
cris.virtualsource.author-orcid101f1394-72d5-4dda-b28f-666a3dee6c70
cris.virtualsource.author-orcidb7cda86d-8924-42a5-973a-d73fee5c630b
datacite.rightsopen.access
dc.contributor.authorNakase, Masaaki
dc.contributor.authorTomii, Daijiro
dc.contributor.authorSamim, Daryoush
dc.contributor.authorGräni, Christoph
dc.contributor.authorPraz, Fabien
dc.contributor.authorLanz, Jonas
dc.contributor.authorStortecky, Stefan
dc.contributor.authorReineke, David
dc.contributor.authorWindecker, Stephan
dc.contributor.authorPilgrim, Thomas
dc.date.accessioned2024-11-18T13:11:17Z
dc.date.available2024-11-18T13:11:17Z
dc.date.issued2024-10-28
dc.descriptionDrs Nakase and Tomii contributed equally to this work and are joint first authors.
dc.description.abstractBackground Vascular complications remain a major concern in transfemoral transcatheter aortic valve replacement (TAVR). The Hostile score has been proposed to stratify risk in TAVR patients with peripheral artery disease. Objectives The authors aimed to assess the validity of the Hostile score in predicting iliofemoral vascular complications after TAVR.Methods In a prospective TAVR registry, we validated the Hostile score for the prediction of puncture and non-puncture site vascular complications. This scoring system integrates the extent (number of lesions, lesion length, and minimum lumen diameter) and complexity (tortuosity, calcification, and the presence of obstruction) of iliofemoral atherosclerosis. Results Of 2,023 patients who underwent transfemoral TAVR with contemporary devices between March 2014 and June 2022, 106 (5.2%) patients experienced puncture site vascular complications and 28 (1.4%) patients experienced non-puncture site vascular complications. The Hostile score was higher in patients with vascular complications than those without complications (1.00 [Q1-Q3: 0-5.00] vs 1.00 [Q1-Q3: 0-4.00]; P < .001). A higher body mass index (OR: 1.23; 95% CI: 1.04-1.50) and the use of Prostar (OR: 6.03; 95% CI: 2.23-16.30) or MANTA (OR: 6.18; 95% CI: 2.67-14.27) compared with ProGlide were independent predictors of puncture site vascular complications, whereas a higher Hostile score (OR: 1.91; 95% CI: 1.55-2.35) and female sex (OR: 2.69; 95% CI: 1.12-6.42) were independent predictors of non-puncture site vascular complications. The area under the receiver-operating characteristic curves for the prediction of puncture site and non-puncture site vascular complications were 0.554 and 0.829, respectively. Conclusions The Hostile score proved useful in predicting non-puncture site vascular complications after TAVR. (SwissTAVI Registry; NCT01368250).
dc.description.sponsorshipClinic of Cardiology
dc.description.sponsorshipClinic of Heart Surgery
dc.identifier.doi10.48620/76307
dc.identifier.pmid39387783
dc.identifier.publisherDOI10.1016/j.jcin.2024.07.009
dc.identifier.urihttps://boris-portal.unibe.ch/handle/20.500.12422/188982
dc.language.isoen
dc.publisherElsevier
dc.relation.ispartofJACC: Cardiovascular Interventions
dc.relation.issn1936-8798
dc.subjectHostile score
dc.subjectaortic stenosis
dc.subjectiliofemoral vascular complication
dc.subjecttranscatheter aortic valve replacement
dc.subject.ddc600 - Technology::610 - Medicine & health
dc.titleImpact of Severity and Extent of Iliofemoral Atherosclerosis on Clinical Outcomes in Patients Undergoing TAVR.
dc.typearticle
dspace.entity.typePublication
dspace.file.typetext
oaire.citation.endPage2363
oaire.citation.issue20
oaire.citation.startPage2353
oaire.citation.volume17
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Heart Surgery
oairecerif.author.affiliationClinic of Cardiology
oairecerif.author.affiliationClinic of Cardiology
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.roleauthor
unibe.contributor.rolecorresponding author
unibe.description.ispublishedpub
unibe.refereedtrue
unibe.subtype.articlejournal

Files

Original bundle
Now showing 1 - 1 of 1
Name:
1-s2.0-S1936879824009646-main.pdf
Size:
1.07 MB
Format:
Adobe Portable Document Format
File Type:
text
License:
https://creativecommons.org/licenses/by/4.0
Content:
published

Collections